Demetri Maxim

Demetri Maxim

Demetri Maxim

CLASS OF 2025

COMPANY

Nephrogen
Founder & CEO

LOCATION

New York

AREA OF FOCUS

AAV gene therapy, CRISPR-Cas genome editing

BIO

Demetri Maxim is the Founder and CEO of Nephrogen and has been actively immersed in kidney disease research since he was 14 years old. He completed his undergraduate and graduate research training at Stanford University under the mentorship of Vivek Bhalla, and world-renowned virologist, Mark Kay. Demetri also formerly worked in Dr. George Church’s lab at Harvard Medical School. Demetri’s family has kidney disease, and he founded Nephrogen based on his graduate research to develop an outright cure for kidney disease.